BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Siddiqui A, Journeycake JM, Borogovac A, George JN. Recognizing and managing hereditary and acquired thrombotic thrombocytopenic purpura in infants and children. Pediatr Blood Cancer 2021;68:e28949. [PMID: 33660913 DOI: 10.1002/pbc.28949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 . Red cell disorders: anaemia, jaundice, polycythaemia and cyanosis. Neonatal Haematology 2022. [DOI: 10.1002/9781119371601.ch2] [Reference Citation Analysis]
2 Graciaa S, Adeagbo S, Fong G, Rollins M, McElfresh P, Zerra PE, Bennett C, Josephson CD, Briones M, Fasano RM, Chonat S. Clinical features and neurological outcomes in pediatric immune-mediated thrombotic thrombocytopenic purpura: A report from a large pediatric hematology center. Pediatr Blood Cancer 2022;:e29992. [PMID: 36151977 DOI: 10.1002/pbc.29992] [Reference Citation Analysis]
3 Taylan C, Thumfart J. Apheresetherapie in der Kindernephrologie. Nephrologe 2022;17:163-168. [DOI: 10.1007/s11560-021-00552-9] [Reference Citation Analysis]
4 Kirpalani A, Garabon J, Amos K, Patel S, Sharma AP, Ganesan SL, Barton M, Cacciotti C, Leppington S, Bakovic L, Huang SS, Knauer MJ, Tole S. Thrombotic thrombocytopenic purpura temporally associated with BNT162b2 vaccination in an adolescent successfully treated with caplacizumab. Br J Haematol 2021. [PMID: 34405400 DOI: 10.1111/bjh.17782] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]